Real World Experience

Russo Partners has a history. From the evolution of biotech to the launch of pharmaceutical marketing 2.0, we have been there every step of the way.

We’re not all talk. PR isn’t just about getting a message out. It’s getting the right message to the right people at the right time. At Russo Partners, we do just that – and so much more.

Home

Introducing our new Sports-Health Alliance.

We develop award-winning PR programs that are at the intersection of health, medicine, and sports. We call on our cadre of athletes, broadcasters and sports business leaders with whom we have close relationships and share the passions of our clients

Learn more about how this strategic approach is shifting perceptions of our clients and their products, fueling their clinical trial enrollment, and doing much, much more

 

At Russo Partners, communications counselors with PhDs, MDs, JDs and MBAs roll up their sleeves to implement integrated programs for biopharma, medtech, diagnostics, healthcare IT and healthcare services companies worldwide.

Since our founding as Noonan/Russo more than 25 years ago, we’ve been on a first-name basis with the people you need to be talking to. Which means you should be talking to us.

Latest News

 

Apr
16

Novavax Announces Closing of Public Offering

GAITHERSBURG, Md., April 16, 2018 (GLOBE NEWSWIRE) — Novavax, Inc. (Nasdaq:NVAX), a clinical-stage biotechnology company committed to delivering novel products to prevent infectious diseases,READ MORE…

Apr
16

Sutro ADC Effectively Targets Folate Receptor Alpha in Ovarian Cancer Preclinical Research

SOUTH SAN FRANCISCO, April 16, 2018 – Sutro Biopharma’s first antibody drug conjugate (ADC) to treat solid tumors was highlyREAD MORE…

Apr
16

Cyclacel Announces Presentation of Phase 1 Clinical Data for CDK Inhibitor CYC065 at AACR 2018 Annual Meeting

BERKELEY HEIGHTS, N.J., April 16, 2018 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) (NASDAQ:CYCCP) (“Cyclacel” or the “Company”), a biopharmaceutical company developing oral therapiesREAD MORE…

Twitter Stream